Quanex Building Products CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Quanex Building Products CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	928	867	890	894	852	1,072	1,222	1,131	1,278	1,838
Cost of revenue	711	672	697	694	659	832	953	853	972	1,338
Gross profit	218	194	193	199	193	241	268	278	306	499
Selling, general and administrative	115	98.1	104	101	89.7	116	117	124	190	277
General and administrative	19.1	17	18.7	18.3	21.7	21.6	24.5	23.5	27.3	40.3
Operating income	36.4	33.9	35.7	-26.4	55.3	81.9	111	111	54.8	-194
Interest expense	36.5	9.6	11.1	9.64	5.25	2.53	2.56	8.14	20.6	55.8
Interest income	0.11	0.09	0.07	0.06	0.03	0.01	0.02	0.25	1.69	2.09
Other non-operating income	-5.48	1.16	1.16	0.12	0.28	0.75	1.04	-5.52	7.85	7.17
Pre-tax income	-5.62	25.5	25.8	-36	50.3	80.1	110	97	42.1	-243
Income tax	-3.77	6.82	-0.8	10.8	11.8	23.1	21.4	14.5	9.02	8.21
Income from continuing operations								97	42.1	-243
Net income	-1.86	18.7	26.6	-46.7	38.5	57	88.3	82.5	33.1	-251
EBITDA	89.5	91.4	87.5	23.2	102	125	151	154	115	-90.5
EPS, basic	-0.05	0.55	0.77	-1.42	1.18	1.72	2.67	2.51	0.91	-5.43
EPS, diluted	-0.05	0.54	0.76	-1.42	1.17	1.70	2.66	2.50	0.90	-5.43
Shares, basic (weighted)	33.9	34.2	34.7	33	32.7	33.2	33	32.8	36.4	46.2
Shares, diluted (weighted)	33.9	34.8	35	33	32.8	33.5	33.2	33	36.6	46.2
Dividend per share	0.16	0.16	0.20	0.32	0.32	0.32	0.32	0.32	0.32	0.32

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	25.5	17.5	29	30.9	51.6	40.1	55.1	58.5	97.7	76
Receivables	83.6	79.4	84	82.9	88.3	108	96	97.3	198	205
Inventory	84.3	87.5	70.7	67.2	61.2	92.5	121	98	276	254
Other current assets	10.5	7.41	7.3	9.35	6.22	8.15	8.66	11.6	5.68	3.76
Total current assets	204	192	191	190	207	249	281	274	611	574
Property, plant and equipment	198	211	201	194	184	179	180	251	402	412
Lease right-of-use assets				0	51.8	52.7	56	46.6	127	155
Goodwill	217	222	220	146	146	149	138	183	575	271
Intangible assets	154	140	122	107	93.1	82.4	65	74.1	598	549
Other non-current assets	6.67	8.98	9.26	8.32	9.13	5.32	4.66	3.19	2.87	4.81
Total assets	780	774	743	645	692	717	725	831	2,320	1,968
Accounts payable	47.8	44.2	52.4	63.6	77.3	86.8	77.9	74.4	124	131
Accrued liabilities	55.1	38.9	46	39.2	38.3	56.2	52.1	50.3	104	95.2
Deferred revenue	0.24	0.63	0.29	1.25	0.76	0.63	0.79	1.02	3.15	2.36
Short-term debt	10.5	21.2	1.22	0.75	0.69	0.85	1.05	2.37	25.7	27.6
Total current liabilities	114	106	102	110	130	158	140	135	273	282
Long-term debt	259	218	209	156	117	52.1	29.6	66.4	737	665
Lease liabilities				0	44.9	45.4	49.3	40.4	118	145
Other non-current liabilities	12.3	15.4	14	15.5	13.4	14	13.5	14.7	19.1	13.8
Total liabilities	413	367	348	315	336	298	260	286	1,309	1,242
Total debt	266	221	195	143	117	52.9	30.7	68.8	763	693
Paid-in capital	255	256	255	255	253	254	252	252	701	700
Retained earnings	214	226	244	186	214	260	337	409	430	165
Treasury stock	-62.4	-49.9	-73	-76.7	-78.6	-72.7	-75.5	-77.6	-74.8	-104
Other comprehensive income	-38.8	-25.1	-30.7	-33.8	-33	-21.8	-49.4	-38.1	-46.4	-35.4
Shareholders' equity	369	408	395	330	356	420	465	546	1,011	726
Total equity	369	408	395	330	356	420	465	546	1,011	0
Total liabilities and equity	780	774	743	645	692	717	725	831	2,320	1,968
Shares outstanding	34.2	34.8	33.3	33	32.8	33.3	33.1	33	47.3	45.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-1.86	18.7	26.6	-46.7	38.5	57	88.3	82.5	33.1	-251
Depreciation and amortization	53.1	57.5	51.8	49.6	47.2	42.7	40.1	42.9	60.3	103
Stock-based compensation	6.09	5.19	1.87	2.05	0.88	1.97	2.29	2.52	2.95	3.69
Deferred income tax	-8.47	-0.11	-5.56	3.26	-0.19	1.79	2.1	5.15	-15.3	-18.5
Change in inventory	5.35	-3.24	17.2	3.8	6.12	-31.4	-32	30	33.5	23.6
Change in payables	-2.27	-4.89	8.33	8.12	15.9	7.1	-3.05	-11.6	-35.8	3.31
Cash from operations	87.3	79.8	105	96.4	101	78.6	98	147	88.8	165
Capital expenditures	-37.2	-34.6	-26.5	-24.9	-25.7	-24	-33.1	-37.4	-37.1	-62.6
Acquisitions	-246	-8.5	0				0	-91.3	-399	0
Cash from investing	-282	-32.6	-26.1	-23.6	-25.2	-18.7	-33	-128	-421	-62
Stock issued	3.4	7.95	4.75	3.29	3.63	16.3	0.69	1.22	0.57	0.21
Share buybacks	0	0	-32	-9.55	-7.23	-11.2	-6.6	-5.59	0	-32.4
Dividends paid	-5.47	-5.52	-7.02	-10.6	-10.5	-10.8	-10.6	-10.6	-12	-14.9
Cash from financing	195	-55.1	-65.8	-71.3	-55.1	-71.9	-45.9	-16.2	385	-127
Exchange rate effect	1.72	-0.09	-1.19	0.32	0.3	0.42	-4.09	0.92	-8.85	-0.29
Net change in cash	2.4	-8.07	11.5	1.87	20.8	-11.6	15	3.38	44.5	-24.9
Free cash flow	50.1	45.2	78.1	71.5	75.1	54.6	64.8	110	51.7	102
Interest paid	14.6	9.02	7.89	9.02	4.72	1.99	1.98	5.74	10.9	52.6
Income taxes paid	3	3.33	4.22	5.08	12.1	22.2	26.4	22.2	18.3	23.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $19.74 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	6.0%	Operating income / revenue.
EBITDA margin	11.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	2.4%	Net income / revenue.
FCF margin	4.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.8%	Cash from operations / revenue.
Return on equity (ROE)	6.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.3%	Net income / average total assets.
Return on invested capital (ROIC)	6.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	15.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.9%	Capital expenditures / revenue.
D&A / revenue	5.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	43.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	14.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	16.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	63.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	23.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	21.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-453.8%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-178.6%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-858.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-703.3%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	85.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	19.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	97.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	16.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-28.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	16.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	15.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	39.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	23.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	26.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	11.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	7.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.23x	Current assets / current liabilities.
Quick ratio	1.03x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.23x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.89x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	33.7%	Total debt / total assets.
Liabilities / assets	62.1%	Total liabilities / total assets.
Net debt	$601.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.87x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.23x	Operating income / interest expense.
Working capital	$332.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	40.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$50.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.95x	Revenue / average total assets.
Fixed asset turnover	4.73x	Revenue / average property, plant and equipment.
Receivables turnover	8.68x	Revenue / average receivables.
Days sales outstanding	42 days	365 x average receivables / revenue.
FCF conversion	200.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	37.6%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.99	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$40.82	Revenue / diluted weighted shares.
FCF per share	$1.99	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.19	Cash from operations / diluted weighted shares.
Book value per share	$16.27	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.10	Tangible book value / shares outstanding.
Cash per share	$1.36	(Cash + short-term investments) / shares outstanding.
Payout ratio	32.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	16.0%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	5.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$906.6M	Share price x shares outstanding.
Enterprise value	$1.51B	Market cap + total debt - cash - short-term investments.
P/E	20.0x	Market cap / net income. Only when net income is positive.
P/S	0.49x	Market cap / revenue.
P/B	1.22x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	9.98x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.23x	Market cap / cash from operations, when positive.
EV/Sales	0.81x	Enterprise value / revenue.
EV/EBIT	13.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.19x	Enterprise value / EBITDA, when both are positive.
EV/FCF	16.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	10.0%	Free cash flow / market cap.
Earnings yield	5.0%	Net income / market cap (the inverse of P/E).
Dividend yield	1.6%	Dividends paid over the period / market cap.
Shareholder yield	2.1%	(Dividends paid + share buybacks) / market cap.

What was Quanex Building Products CORP's revenue in fiscal 2025?

Quanex Building Products CORP reported revenue of $1.84B for fiscal 2025, 43.8% higher than the year before.

Was Quanex Building Products CORP profitable in fiscal 2025?

No. It reported a net loss of $250.8M.

How much free cash flow did Quanex Building Products CORP generate in fiscal 2025?

Cash from operations of $164.9M minus capital expenditures of $62.6M left free cash flow of $102.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Quanex Building Products CORP